Inhaled corticosteroids (ICS), short- and long-acting β 2-agonists (SABA and LABA), long-acting muscarinic antagonists (LAMA) and fixed-dose combinations of LABA and ICS are the cornerstones of ...

Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.

The combination of an inhaled corticosteroid, long-acting muscarinic antagonist, and a long-acting beta2 adrenergic agonist is important to GSK as it must replace lost sales from its ageing ...

Key life-cycle management strategies for the future include combining drugs from different classes, of which the LABA/LAMA (long-acting muscarinic agonist) combinations are set to be the greatest ...

Umeclidinium is a long-acting muscarinic antagonist ... The pharmacologic effects of beta2-adrenergic agonist drugs, including vilanterol, are at least in part attributable to stimulation of ...

Enerzair (formerly QVM149) consists of long-acting beta agonist (LABA) indacaterol, long-acting muscarinic antagonist (LAMA) glycopyrronium, and inhaled corticosteroid (ICS) mometasone furoate ...

Longer-acting glucagon-like peptide-1 (GLP-1) receptor agonists and devices have been recently developed and include once-weekly exenatide, dulaglutide, albiglutide, semaglutide and miniosmotic ...

Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist ... combining a long-acting muscarinic antagonist, umeclidinium ...

Muscarinic (M) receptors involved in the ... If the equivalence of tiotropium with long-acting β2-agonists will be demonstrated in terms of efficacy, at least in some asthma phenotypes ...

Trelegy Ellipta, a triple-therapy inhaler containing an inhaled corticosteroid (ICS), a long-acting muscarinic antagonist (LAMA), and a long-acting beta-agonist (LABA), was found to offer ...